about
Uveitic macular edemaBirdshot retinochoroidopathyOcular and central nervous system lymphoma: clinical features and diagnosis[Birdshot retinochoroidopathy: Key messages].Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.[Current status of retinal detachment in AIDS patients]Primate model of uveoretinitis and vasculitis/experimental autoimmune uveoretinitis induced in cynomolgus monkeys by retinal s antigen.Laser flare photometry in the therapeutic management of bacterial chronic pseudophakic endophthalmitis.Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families.CMV retinitis in the era of HAART.Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.Ocular tuberculosis.Ocular sarcoidosis.Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.Testing ocular fluids in uveitis.Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis.Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphomaFoveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).Failure to Integrate Quantitative Measurement Methods of Ocular Inflammation Hampers Clinical Practice and Trials on New Therapies for Posterior Uveitis.Choroidal and adnexal extranodal marginal zone B-cell lymphoma: presentation, imaging findings, and therapeutic management in a series of nine cases.Animal models of intraocular lymphomas.Cataract surgery in childhood uveitis.Deep sclerectomy and trabeculectomy in uveitic glaucoma.Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology.Understanding uveitis: the impact of research on visual outcomes.The gold standard of noninfectious uveitis: corticosteroids.Use of fluorescein angiography in the diagnosis and management of uveitis.Diagnostic approach in optic neuropathy.Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra.Chronic Herpetic Retinitis: Clinical Features and Long-Term Outcomes.Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.Uveitic macular edema.Neuro-ophthalmological conditions: Study of the clinical care pathway.Birdshot Retinochoroidopathy: Prognostic Factors of Long-term Visual Outcome.Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
P50
Q28080457-9F00AAAE-1209-442B-8421-8A03AD92EF9AQ28140904-F636C577-782E-4446-8F17-9E0BFD6A0814Q28206092-ADADB536-2DC7-40A6-B201-9EE66DDB4E90Q30249360-0DB2EC6E-9A5C-4ACD-8B7D-35FF51C79AD5Q30659915-1D849B21-C76F-4D7E-8F83-7ABAD44FF1DEQ30977607-ADB4F282-B59B-4CFA-87F1-66DF4E76106EQ33329078-BF99E153-87BE-4803-A807-A59E85B55010Q33394922-E365B9A1-5DE3-4F49-98FC-1CB6C1FE3FC2Q33416260-5E809923-E798-45BD-8C85-367F10830301Q33804055-F7AE97E5-7F2D-49A3-A3F4-CA7263399D29Q34017453-89302999-5938-4907-9B7D-48EF4B762734Q34120539-A7E8B30A-3824-43CF-A64F-EBB2C7E850AAQ34275700-56EC9537-38FD-4F9E-BC28-E2838797A823Q34583801-2C9CBF8E-5BEF-4EA0-BA7F-D4B329B6D080Q34998771-49654C3C-E294-4DBA-8DB3-8A4EECCBCEA8Q35590463-AEFEE662-37F4-4CB7-BE56-2A28A152EFFCQ35662608-19013703-654F-4B58-8300-EE0CDE27336BQ35690424-1FE4DAA7-D534-43F8-A8B0-33ACE2EC7A3AQ36145665-CE1CE6AD-8A65-4C6F-8CC2-EFF58C2A4BD5Q36150378-EB5DF6ED-0AF9-49DE-824B-B417063D9128Q36219020-F5FBD459-A74A-4D2F-B17A-155EAFE41972Q37005945-90AAA8C0-938D-4F8C-A1C0-D02F71A1BEA0Q37141743-30F61D33-BC50-4ACD-910D-83329AAF73CDQ37223401-4DF7EFB2-0784-404C-B8C7-019DD5F0C40DQ37448166-70B4392C-B174-41E4-9F3F-BC957653708FQ37830790-30926A5D-BF8F-4FC1-A492-1F0EBE9660B7Q37857376-3C819574-FDF6-4CA9-A2DE-B4529CB7DC92Q37909585-B77B5DA9-F420-4367-A3E2-829EF5BDEFBDQ38003879-38294606-62DF-435D-9BFA-C45DB6E06ACBQ38041342-EC5B7A9F-CB87-4AF2-8FC6-28DC7A588DE7Q38045524-82D5B326-FE00-4916-A270-30CC13A71ABAQ38364935-7F6BF088-0A70-41D6-8ED4-9D59F42B2EAEQ38719316-0F4553D8-BE81-4777-8D90-9E0F5F5FF6C1Q38817235-A6169561-4A7A-4CC3-9FE2-7CC60CC893AEQ38852119-84879840-BCEC-47CF-9357-E9424DA5A661Q39363007-9540F241-7B31-4AE2-9520-798413914D73Q39491461-9CAB4DAA-5638-47FF-B82F-B5AA634D9CC2Q39898518-6F429AF3-AC1E-4DDD-8321-5DBADA6C4815Q39899175-50016CA7-6345-4776-A7D5-8FE625C992F7Q39978275-11D6A4F7-8CCC-461B-A79D-DE98644D0F8B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Phuc LeHoang
@ast
Phuc LeHoang
@en
Phuc LeHoang
@es
Phuc LeHoang
@nl
Phuc LeHoang
@sl
type
label
Phuc LeHoang
@ast
Phuc LeHoang
@en
Phuc LeHoang
@es
Phuc LeHoang
@nl
Phuc LeHoang
@sl
prefLabel
Phuc LeHoang
@ast
Phuc LeHoang
@en
Phuc LeHoang
@es
Phuc LeHoang
@nl
Phuc LeHoang
@sl
P106
P31
P496
0000-0003-4722-1831